Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer
Clinical trial NCT02967770 · WITHDRAWN
Trial details
- NCT number
- NCT02967770
- Sponsor
- Georgetown University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-08-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.